DLB - Dolby Laboratories Inc Stock Price, Fair Value and News

83.85+0.23 (+0.28%)Market Closed

Market Summary

83.85+0.23

Market Closed

0.28%

DLB Stock Price

View Fullscreen

DLB RSI Chart

DLB Valuation

Market Cap

8.0B

Price/Earnings (Trailing)

42.18

Price/Sales (Trailing)

6.33

EV/EBITDA

22.99

Price/Free Cashflow

21.98

DLB Price/Sales (Trailing)

DLB Profitability

Operating Margin

88.35%

EBT Margin

18.55%

Return on Equity

7.81%

Return on Assets

6.25%

Free Cashflow Yield

4.55%

DLB Fundamentals

DLB Revenue

Revenue (TTM)

1.3B

Rev. Growth (Yr)

-3.02%

Rev. Growth (Qtr)

15.51%

DLB Earnings

Earnings (TTM)

190.4M

Earnings Growth (Yr)

2.23%

Earnings Growth (Qtr)

46.06%

Breaking Down DLB Revenue

Last 7 days

1.4%

Last 30 days

7.6%

Last 90 days

7.5%

Trailing 12 Months

0.6%

How does DLB drawdown profile look like?

DLB Financial Health

Current Ratio

3.5

DLB Investor Care

Dividend Yield

1.39%

Dividend/Share (TTM)

1.11

Buy Backs (1Y)

0.11%

Diluted EPS (TTM)

1.96

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.3B	0	0	0
2023	1.3B	1.3B	1.3B	1.3B
2022	1.3B	1.3B	1.3B	1.2B
2021	1.2B	1.3B	1.3B	1.2B
2020	1.2B	1.2B	1.2B	1.3B
2019	1.1B	1.2B	1.2B	1.2B
2018	1.1B	1.1B	1.1B	1.1B
2017	1.0B	1.1B	1.1B	1.1B
2016	979.6M	1.0B	1.0B	1.1B
2015	956.5M	964.8M	970.6M	977.2M
2014	933.6M	949.9M	960.2M	963.1M
2013	922.0M	918.8M	909.7M	904.3M
2012	959.7M	951.0M	933.0M	935.4M
2011	950.8M	939.5M	955.5M	947.0M
2010	821.1M	871.9M	922.7M	944.2M
2009	0	679.9M	719.5M	770.3M
2008	0	0	640.2M	0

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Dolby Laboratories Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 01, 2024	rollins emily	sold	-80,880	80.88	-1,000	-
Feb 28, 2024	pendleton todd	sold	-1,992,800	81.6888	-24,395	svp, chief marketing officer
Feb 28, 2024	pendleton todd	acquired	844,997	70.2876	12,022	svp, chief marketing officer
Feb 09, 2024	couling john d	sold	-2,711,900	80.8074	-33,560	svp, entertainment
Feb 09, 2024	couling john d	acquired	1,850,870	55.1511	33,560	svp, entertainment
Feb 08, 2024	couling john d	sold	-4,000,000	80.00	-50,000	svp, entertainment
Feb 08, 2024	couling john d	acquired	2,149,000	42.98	50,000	svp, entertainment
Feb 06, 2024	gotcher peter c	acquired	-	-	2,952	-
Feb 06, 2024	dolby david	acquired	-	-	2,952	-
Feb 06, 2024	prophet tony a	acquired	-	-	2,952	-

Which funds bought or sold DLB recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 17, 2024	New Covenant Trust Company, N.A.	new	-	2,429	2,429	-%
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-5.88	-461,691	4,961,530	0.01%
May 16, 2024	Global Financial Private Client, LLC	unchanged	-	-97.00	3,092	-%
May 16, 2024	Redwood Investment Management, LLC	sold off	-100	-429,000	-	-%
May 16, 2024	COMERICA BANK	reduced	-4.83	-310,073	3,832,350	0.02%
May 16, 2024	B. Riley Wealth Advisors, Inc.	added	41.35	98,059	425,069	0.01%
May 16, 2024	2Xideas AG	reduced	-9.8	-1,451,610	10,331,600	1.26%
May 16, 2024	Tidal Investments LLC	added	53.86	291,250	878,998	0.01%
May 16, 2024	JANE STREET GROUP, LLC	reduced	-75.55	-3,690,140	1,150,250	-%
May 15, 2024	LM Advisors LLC	sold off	-100	-17,063	-	-%

Are Funds Buying or Selling DLB?

Are funds buying DLB calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own DLB

No. of Funds

Unveiling Dolby Laboratories Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	10.80%	6,394,750	SC 13G/A
Feb 13, 2024	kayne anderson rudnick investment management llc	9.19%	5,420,205	SC 13G/A
Feb 08, 2024	morgan stanley	7.8%	4,593,133	SC 13G/A
Jan 24, 2024	blackrock inc.	9.8%	5,797,685	SC 13G/A
Mar 10, 2023	vanguard group inc	10.06%	6,012,094	SC 13G/A
Feb 14, 2023	kayne anderson rudnick investment management llc	8.54%	5,110,252	SC 13G
Feb 10, 2023	clearbridge investments, llc	4.8%	2,903,393	SC 13G/A
Feb 09, 2023	morgan stanley	7.1%	4,261,695	SC 13G/A
Feb 09, 2023	vanguard group inc	9.94%	5,963,672	SC 13G/A
Feb 03, 2023	blackrock inc.	5.2%	3,117,785	SC 13G

Recent SEC filings of Dolby Laboratories Inc

View All Filings

Date Filed	Form Type	Document
May 17, 2024	4	Insider Trading
May 15, 2024	4	Insider Trading
May 02, 2024	8-K	Current Report
May 02, 2024	10-Q	Quarterly Report
Apr 10, 2024	UPLOAD	UPLOAD
Mar 11, 2024	CORRESP	CORRESP
Mar 05, 2024	4	Insider Trading
Mar 01, 2024	4	Insider Trading
Mar 01, 2024	144	Notice of Insider Sale Intent
Feb 28, 2024	144	Notice of Insider Sale Intent

Peers (Alternatives to Dolby Laboratories Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ADP	103.3B	18.9B	3.89%	17.13%	27.92	5.46	7.08%	13.46%
CTAS	70.2B	9.4B	3.55%	46.60%	46.72	7.46	9.34%	15.98%
CPRT	52.4B	4.1B	0.93%	23.38%	38.65	12.91	10.52%	25.37%
EFX	30.8B	5.4B	4.69%	18.29%	55.13	5.75	5.76%	-4.95%
BAH	19.8B	10.3B	8.58%	63.14%	48.27	1.91	13.90%	-5.05%
ALLE	10.9B	3.6B	-1.06%	12.63%	20.13	3	4.33%	10.69%
MID-CAP
RHI	7.4B	6.2B	2.28%	3.37%	21.08	1.21	-13.83%	-42.32%
AL	5.5B	2.7B	1.27%	26.05%	9.4	2.02	15.08%	16.51%
SRCL	4.3B	2.6B	-4.39%	7.90%	-221.54	1.64	-3.11%	-123.81%
ABM	3.0B	8.2B	7.93%	6.44%	11.58	0.36	3.98%	33.49%
SMALL-CAP
AZZ	1.9B	2.7B	1.35%	107.67%	18.93	0.71	104.63%	188.16%
ALTG	285.4M	1.9B	-26.28%	-43.39%	32.07	0.15	15.20%	-4.30%
ARC	118.7M	283.1M	3.77%	-7.09%	13.57	0.42	-0.83%	-20.92%
AQMS	48.7M	212.0K	-14.00%	-58.65%	-1.94	213.63	-40.62%	-60.52%
AWX	9.4M	81.0M	4.35%	-6.98%	-8.5	0.12	-4.98%	-14.33%

Dolby Laboratories Inc News

Latest updates

Dolby Laboratories Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	15.5%	365	316	291	298	376	335	278	290	334	352	285	287	320	390	271	247	352	292	299	302	338
Cost Of Revenue	21.0%	39.00	32.00	36.00	42.00	41.00	34.00	37.00	36.00	36.00	33.00	31.00	32.00	32.00	35.00	42.00	30.00	37.00	37.00	46.00	40.00	37.00
Gross Profit	14.9%	326	284	255	257	335	300	241	254	299	319	254	255	287	355	229	217	315	255	253	262	302
Operating Expenses	-0.2%	217	217	259	241	226	206	214	208	256	228	214	199	204	190	199	183	209	206	202	228	199
S&GA Expenses	14.0%	90.00	79.00	91.00	86.00	96.00	82.00	90.00	87.00	84.00	97.00	98.00	81.00	78.00	75.00	81.00	71.00	88.00	95.00	82.00	83.00	93.00
R&D Expenses	-6.8%	62.00	67.00	70.00	69.00	68.00	64.00	62.00	63.00	67.00	69.00	62.00	62.00	66.00	64.00	62.00	60.00	60.00	58.00	60.00	60.00	59.00
EBITDA Margin	1.3%	0.25*	0.24*	0.28*	0.28*	0.30*	0.25*	0.25*	0.26*	0.27*	0.31*	0.35*	0.35*	0.35*	0.35*	-	-	-	-	-	-	-
Interest Expenses	-	-	-	28.00	0.00	-0.03	0.00	6.00	0.00	0.00	0.00	3.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Income Taxes	76.7%	24.00	13.00	-0.89	7.00	21.00	21.00	3.00	10.00	7.00	11.00	-1.17	5.00	9.00	24.00	8.00	-27.40	22.00	6.00	12.00	2.00	36.00
Earnings Before Taxes	50.6%	122	81.00	9.00	24.00	117	100	31.00	49.00	43.00	91.00	43.00	59.00	85.00	167	34.00	40.00	111	54.00	56.00	42.00	110
EBT Margin	2.8%	0.19*	0.18*	0.19*	0.21*	0.23*	0.18*	0.17*	0.18*	0.19*	0.22*	0.28*	0.27*	0.27*	0.28*	-	-	-	-	-	-	-
Net Income	46.1%	98.00	67.00	9.00	16.00	96.00	79.00	28.00	40.00	37.00	80.00	44.00	55.00	76.00	135	27.00	67.00	88.00	49.00	44.00	40.00	73.00
Net Income Margin	2.0%	0.15*	0.15*	0.15*	0.17*	0.19*	0.15*	0.15*	0.16*	0.17*	0.21*	0.24*	0.23*	0.25*	0.25*	-	-	-	-	-	-	-
Free Cashflow	7367.2%	172	2.00	77.00	114	97.00	49.00	41.00	161	51.00	17.00	98.00	159	70.00	67.00	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	3.7%	3,045	2,936	2,980	3,008	2,836	2,749	2,690	2,920	3,063	3,105	3,106	3,135	3,106	3,097	2,917	2,904	2,945	2,893	2,822	2,810	2,847
Current Assets	6.9%	1,552	1,451	1,488	1,469	1,463	1,349	1,311	1,505	1,622	1,695	1,760	1,773	1,751	1,725	1,547	1,503	1,460	1,401	1,382	1,339	1,396
Cash Equivalents	25.5%	824	657	745	765	688	631	628	867	909	1,064	1,233	1,227	1,113	1,119	1,080	863	734	753	806	724	735
Inventory	-4.7%	36.00	38.00	36.00	32.00	30.00	26.00	24.00	24.00	17.00	13.00	11.00	12.00	15.00	20.00	26.00	29.00	28.00	29.00	32.00	39.00	35.00
Net PPE	0.5%	481	479	482	502	508	512	513	518	528	534	534	538	543	544	542	547	551	549	537	525	538
Goodwill	-0.4%	409	410	408	426	370	369	365	368	372	340	341	338	338	339	337	336	333	335	335	336	327
Liabilities	5.9%	607	573	608	625	480	456	439	460	458	462	501	507	512	526	479	467	576	555	509	490	494
Current Liabilities	12.4%	443	394	422	423	314	290	278	285	281	283	316	309	309	316	267	258	307	293	307	278	265
Shareholder's Equity	3.9%	2,438	2,346	2,355	2,366	2,356	2,293	2,251	2,460	2,605	2,643	2,604	2,628	2,594	2,571	2,438	2,437	2,369	2,339	2,313	2,320	2,353
Retained Earnings	3.5%	2,450	2,367	2,392	2,397	2,378	2,319	2,298	2,485	2,615	2,649	2,608	2,626	2,592	2,566	2,443	2,448	2,396	2,351	2,328	2,329	2,362
Additional Paid-In Capital	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated Depreciation	-	597	-	577	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shares Outstanding	0.4%	96.00	95.00	96.00	96.00	96.00	96.00	100	100	101	101	101	101	101	101	101	101	101	100	102	101	102
Minority Interest	2.0%	17.00	16.00	17.00	16.00	5.00	5.00	5.00	5.00	5.00	5.00	6.00	6.00	6.00	6.00	6.00	6.00	5.00	5.00	6.00	6.00	6.00
Float	-	-	-	-	-	4,100	-	-	-	4,600	-	-	-	5,700	-	-	-	3,100	-	-	-	3,200

Cashflow (Last 12 Months)

(In Millions)

Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	2057.3%	181	8.00	85.00	121	105	56.00	51.00	173	63.00	32.00	110	172	83.00	82.00	113	134	66.00	31.00	130	91.00	49.00
Share Based Compensation	-9.3%	29.00	32.00	28.00	29.00	30.00	31.00	27.00	28.00	28.00	33.00	24.00	25.00	24.00	26.00	22.00	21.00	21.00	23.00	17.00	19.00	19.00
Cashflow From Investing	-2923.5%	-17.87	1.00	-19.71	22.00	24.00	28.00	-40.72	-8.16	-120	-126	-14.96	-14.19	-14.26	-1.50	155	27.00	-9.80	-37.41	17.00	-9.87	-21.89
Cashflow From Financing	64.7%	-44.16	-125	-42.80	-36.83	-67.10	-90.09	-242	-197	-97.42	-72.84	-86.86	-44.88	-74.43	-46.34	-53.86	-37.43	-68.21	-48.28	-62.70	-91.13	-93.02
Dividend Payments	0.6%	29.00	29.00	26.00	26.00	26.00	26.00	24.00	25.00	25.00	25.00	22.00	22.00	22.00	22.00	22.00	22.00	22.00	22.00	19.00	19.00	19.00
Buy Backs	-68.8%	25.00	80.00	25.00	25.00	50.00	49.00	220	190	85.00	36.00	96.00	39.00	71.00	40.00	45.00	27.00	72.00	30.00	54.00	89.00	85.00

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

DLB Income Statement

2024-03-29

Interim Condensed Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 29, 2024	Mar. 31, 2023	Mar. 29, 2024	Mar. 31, 2023
Revenue:
Revenue	$ 364,523	$ 375,891	$ 680,097	$ 710,812
Total revenue	364,523	375,891	680,097	710,812
Cost of revenue:
Total cost of revenue	38,777	41,049	70,837	75,499
Gross profit	325,746	334,842	609,260	635,313
Operating expenses:
Research and development	62,493	67,951	129,526	132,401
Sales and marketing	90,038	95,695	169,041	177,900
General and administrative	66,742	61,939	131,908	121,911
Restructuring charges	(2,495)	33	3,596	(211)
Total operating expenses	216,778	225,618	434,071	432,001
Operating income	108,968	109,224	175,189	203,312
Other income/(expense):
Interest income/(expense), net	8,597	6,807	17,784	11,604
Other income, net	4,183	1,250	9,608	2,347
Total other income	12,780	8,057	27,392	13,951
Income before income taxes	121,748	117,281	202,581	217,263
Provision for income taxes	(23,534)	(21,398)	(36,786)	(41,932)
Net income including noncontrolling interest	98,214	95,883	165,795	175,331
Less: net income attributable to noncontrolling interest	(384)	(187)	(984)	(260)
Net income attributable to Dolby Laboratories, Inc.	$ 97,830	$ 95,696	$ 164,811	$ 175,071
Net income per share:
Basic (in usd per share)	$ 1.02	$ 1.00	$ 1.72	$ 1.83
Diluted (in usd per share)	$ 1.01	$ 0.98	$ 1.69	$ 1.80
Weighted-average shares outstanding:
Basic (in shares)	95,718	95,820	95,547	95,862
Diluted (in shares)	96,856	97,298	97,397	97,392
Cash dividend declared per common share (in dollars per share)	$ 0.30	$ 0.27	$ 0.60	$ 0.54
Cash dividend paid per common share (in dollars per share)	$ 0.30	$ 0.27	$ 0.60	$ 0.54
Licensing
Revenue:
Revenue	$ 338,240	$ 351,608	$ 632,007	$ 659,619
Cost of revenue:
Cost of revenue	15,318	21,365	31,054	34,724
Products and services
Revenue:
Revenue	26,283	24,283	48,090	51,193
Cost of revenue:
Cost of revenue	$ 23,459	$ 19,684	$ 39,783	$ 40,775

DLB Balance Sheet

2024-03-29

Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 29, 2024	Sep. 29, 2023
Current assets:
Cash and cash equivalents	$ 709,535	$ 745,364
Restricted cash	114,821	72,602
Short-term investments	115,863	139,148
Accounts receivable, net of allowance for credit losses of $6,213 and $9,683	282,131	262,245
Contract assets, net of allowance for credit losses of $105 and $138	243,170	182,130
Inventories, net	35,797	35,623
Prepaid expenses and other current assets	50,421	50,692
Total current assets	1,551,738	1,487,804
Long-term investments	127,973	97,812
Property, plant, and equipment, net	481,492	481,581
Operating lease right-of-use assets	43,057	40,199
Intangible assets, net	152,149	167,427
Goodwill	408,652	408,409
Other non-current assets	71,173	94,674
Deferred taxes	208,494	201,860
Total assets	3,044,728	2,979,766
Current liabilities:
Accounts payable	19,727	20,925
Accrued liabilities	362,883	351,399
Income taxes payable	8,384	4,769
Contract liabilities	37,702	31,505
Operating lease liabilities	14,206	13,628
Total current liabilities	442,902	422,226
Non-current contract liabilities	36,453	39,997
Non-current operating lease liabilities	37,711	37,020
Other non-current liabilities	89,975	108,339
Total liabilities	607,041	607,582
Stockholders’ equity:
Retained earnings	2,449,876	2,391,990
Accumulated other comprehensive loss	(29,068)	(36,984)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,420,902	2,355,100
Noncontrolling interest	16,785	17,084
Total stockholders’ equity	2,437,687	2,372,184
Total liabilities and stockholders’ equity	3,044,728	2,979,766
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 59,737,770 shares issued and outstanding at March 29, 2024 and 59,673,633 at September 29, 2023
Stockholders’ equity:
Common stock	53	53
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 36,085,779 shares issued and outstanding at March 29, 2024 and 36,085,779 at September 29, 2023
Stockholders’ equity:
Common stock	$ 41	$ 41

About Dolby Laboratories Inc

Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, and home entertainment devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices. Its audio technologies also include DD, a digital audio coding technology that provides multichannel sound to applications; DD+, a digital audio coding technology that offers audio transmission for a range of media applications and devices; Dolby TrueHD, a digital audio coding technology providing encoding for media application; Dolby Vision, an imaging technology for cinema and media devices; Dolby Voice, an audio communications technology that emulates the in-person meeting experience; and HEVC, a digital video codec with high bandwidth efficiency for media devices. In addition, the company offers digital cinema servers, cinema processors, amplifiers, loudspeakers, and audio and imaging hardware and software products for the cinema, television, broadcast, communication, and entertainment industries. Further, it provides 3-D glasses and kits; and various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, cinema operators, broadcasters, and video game designers. It sells its products directly to the end users, as well as through dealers and distributors worldwide. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.

CEO	Mr. Kevin J. Yeaman
WEBSITE	dolby.com
INDUSTRY	Information Technology Services
EMPLOYEES	2336

Dolby Laboratories Inc Frequently Asked Questions

What is the ticker symbol for Dolby Laboratories Inc? What does DLB stand for in stocks?

DLB is the stock ticker symbol of Dolby Laboratories Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Dolby Laboratories Inc (DLB)?

As of Fri May 17 2024, market cap of Dolby Laboratories Inc is 8.03 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of DLB stock?

You can check DLB's fair value in chart for subscribers.

What is the fair value of DLB stock?

You can check DLB's fair value in chart for subscribers. The fair value of Dolby Laboratories Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Dolby Laboratories Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for DLB so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Dolby Laboratories Inc a good stock to buy?

The fair value guage provides a quick view whether DLB is over valued or under valued. Whether Dolby Laboratories Inc is cheap or expensive depends on the assumptions which impact Dolby Laboratories Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DLB.

What is Dolby Laboratories Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, DLB's PE ratio (Price to Earnings) is 42.18 and Price to Sales (PS) ratio is 6.33. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DLB PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Dolby Laboratories Inc's stock?

In the past 10 years, Dolby Laboratories Inc has provided 0.087 (multiply by 100 for percentage) rate of return.